Artelo Biosciences ARTL
NASDAQ ARTL
$2.57 -0.05 (-1.91%)
As of: Oct 21, 2026 · 3:59 PM EDT

Artelo Biosciences (ARTL) Total Debt (2017 - 2025)

Updated

Artelo Biosciences (ARTL) recorded Total Debt of $437,000 in Q4 2025, down 50.1% from the prior quarter.

Analysis

Artelo Biosciences (ARTL) Total Debt (2017 - 2025) Analysis & Trends

Starting with Q2 2017, Artelo Biosciences' Total Debt history includes 4 quarters.

  • The Q4 2025 figure is the lowest quarterly Total Debt since Q3 2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 54.91 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 49.04 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 70.82 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 53.91 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 9.59 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 32.35 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 57.30 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 26.25 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 63.19 Bn
10 Artelo Biosciences 52,106.49 -5.08 Mn - 437,000.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 437,000.00
Sep 30, 2025 875,000.00
May 31, 2017 29,720.00
Feb 28, 2017 29,569.00
API Access

Artelo Biosciences Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=ARTL&period=max&api_key=YOUR_API_KEY